Filipovic A - Search Results

1

LMTK3 is implicated in endocrine resistance via multiple signaling pathways.

Stebbing J, Filipovic A, Lit LC, Blighe K, Grothey A, Xu Y, Miki Y, Chow LW, Coombes RC, Sasano H, Shaw JA, Giamas G. Stebbing J, et al. Among authors: filipovic a. Oncogene. 2013 Jul 11;32(28):3371-80. doi: 10.1038/onc.2012.343. Epub 2012 Aug 6. Oncogene. 2013. PMID: 22869149

2

LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome.

Stebbing J, Filipovic A, Ellis IO, Green AR, D'Silva TR, Lenz HJ, Coombes RC, Wang T, Lee SC, Giamas G. Stebbing J, et al. Among authors: filipovic a. Breast Cancer Res Treat. 2012 Apr;132(2):537-44. doi: 10.1007/s10549-011-1622-z. Epub 2011 Jun 14. Breast Cancer Res Treat. 2012. PMID: 21671015

3

Claudin-1 as a promoter of EMT in hepatocellular carcinoma.

Stebbing J, Filipović A, Giamas G. Stebbing J, et al. Among authors: filipovic a. Oncogene. 2013 Oct 10;32(41):4871-2. doi: 10.1038/onc.2012.591. Epub 2013 Jan 14. Oncogene. 2013. PMID: 23318416

4

Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer.

Giamas G, Filipović A, Jacob J, Messier W, Zhang H, Yang D, Zhang W, Shifa BA, Photiou A, Tralau-Stewart C, Castellano L, Green AR, Coombes RC, Ellis IO, Ali S, Lenz HJ, Stebbing J. Giamas G, et al. Among authors: filipovic a. Nat Med. 2011 Jun;17(6):715-9. doi: 10.1038/nm.2351. Epub 2011 May 22. Nat Med. 2011. PMID: 21602804

5

Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo.

Lombardo Y, Filipović A, Molyneux G, Periyasamy M, Giamas G, Hu Y, Trivedi PS, Wang J, Yagüe E, Michel L, Coombes RC. Lombardo Y, et al. Among authors: filipovic a. Proc Natl Acad Sci U S A. 2012 Oct 9;109(41):16558-63. doi: 10.1073/pnas.1206268109. Epub 2012 Sep 24. Proc Natl Acad Sci U S A. 2012. PMID: 23012411 Free PMC article.

6

Cancer stem cells--therapeutic targeting or therapy?

Filipovic A, Stebbing J, Giamas G. Filipovic A, et al. Lancet Oncol. 2013 Jun;14(7):579-80. doi: 10.1016/S1470-2045(13)70258-4. Lancet Oncol. 2013. PMID: 23725700 No abstract available.

7

SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1.

Zhang H, Xu Y, Filipovic A, Lit LC, Koo CY, Stebbing J, Giamas G. Zhang H, et al. Among authors: filipovic a. Br J Cancer. 2013 Nov 12;109(10):2675-84. doi: 10.1038/bjc.2013.628. Epub 2013 Oct 15. Br J Cancer. 2013. PMID: 24129246 Free PMC article.

8

Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution.

Stebbing J, Filipović A, Giamas G. Stebbing J, et al. Among authors: filipovic a. Oncotarget. 2011 Jun;2(6):428-9. doi: 10.18632/oncotarget.291. Oncotarget. 2011. PMID: 21680955 Free PMC article. No abstract available.

9

The role of genes co-amplified with nicastrin in breast invasive carcinoma.

Sarajlić A, Filipović A, Janjić V, Coombes RC, Pržulj N. Sarajlić A, et al. Among authors: filipovic a. Breast Cancer Res Treat. 2014 Jan;143(2):393-401. doi: 10.1007/s10549-013-2805-6. Epub 2013 Dec 13. Breast Cancer Res Treat. 2014. PMID: 24337538

10

Biological and clinical implications of nicastrin expression in invasive breast cancer.

Filipović A, Gronau JH, Green AR, Wang J, Vallath S, Shao D, Rasul S, Ellis IO, Yagüe E, Sturge J, Coombes RC. Filipović A, et al. Breast Cancer Res Treat. 2011 Jan;125(1):43-53. doi: 10.1007/s10549-010-0823-1. Epub 2010 Mar 12. Breast Cancer Res Treat. 2011. PMID: 20224929

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

107 results

Search Page